Venous thromboembolism following minimally invasive surgery among women with endometrial cancer

• In contrast to laparotomy, venous thromboembolism (VTE) among women after minimally invasive surgery for endometrial cancer is rare.
• VTE rate after minimally invasive surgery did not differ by mode of thromboprophylaxis received
• Pharmacologic prophylaxis may not be warranted for women undergoing minimally invasive surgery for endometrial cancer

ObjectiveTo determine the rate of venous thromboembolism (VTE) among women undergoing minimally invasive surgery (MIS) for endometrial cancer.MethodsWomen undergoing robotic or laparoscopic hysterectomy for endometrial carcinoma or complex hyperplasia with atypia were identified between January 2009 and 2014 in a community based health care system. Patient data including age, race, cancer stage, grade, procedure type, length of hospital stay, use of prophylaxis, and diagnosis of VTE were collected retrospectively. The primary outcome was the rate of VTE within 30 days following surgery. Fischer's exact tests were performed to evaluate factors associated with VTE.ResultsDuring the study period, 1433 patients underwent MIS for endometrial cancer, with 20 excluded due to known thrombophilia, VTE history, or long-term anticoagulation. A total of 1413 patients were included (739 robotic and 674 laparoscopic cases). All women received mechanical prophylaxis per hospital policy and 61% had additional pharmacologic prophylaxis. The rate of VTE was 0.35% (5/1413), which did not differ among those who received pharmacologic compared to mechanical prophylaxis (0.23% [2/865] versus 0.55% [3/548] respectively, p = 0.38). No factors were associated with increased risk of VTE due to the low event rate.ConclusionVTE in patients undergoing MIS for endometrial cancer was very low irrespective of the mode of prophylaxis received in this large cohort. National guidelines for VTE prophylaxis need to differentiate the low risk associated with MIS surgery from the risk associated with laparotomy for endometrial cancer. We recommend mechanical prophylaxis is sufficient for these women undergoing MIS.